INTERNATIONAL PATENT: DUALITY BIOLOGICS (SHANGHAI) CO., LTD., 映恩生物科技（上海）有限公司 FILES APPLICATION FOR "ANTI-DLL3 ANTIBODY, ANTIBODY-DRUG CONJUGATE AND USE THEREOF"

GENEVA, Dec. 8 -- DUALITY BIOLOGICS (SHANGHAI) CO., LTD. (1106, 868 Yinghua RoadPudong New Area, Shanghai 201204), 映恩生物科技（上海）有限公司 (中国上海市浦东新区樱花路868号1106) filed a patent application (PCT/CN2025/097673) for "ANTI-DLL3 ANTIBODY, ANTIBODY-DRUG CONJUGATE, AND USE THEREOF" on May 28, 2025. With publication no. WO/2025/247255, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Orga...